| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/07/2009 | CA2405518C Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/07/2009 | CA2368165C Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 07/07/2009 | CA2168029C Prosaposin and cytokine-derived peptides as therapeutic agents |
| 07/04/2009 | CA2648836A1 New derivatives of 1h-indol-1-urea, a process for their preparation and pharmaceutical compositions containing them |
| 07/02/2009 | WO2009082268A2 LIGANDS OF α-ADRENOCEPTORS AND OF DOPAMINE, HISTAMINE, IMIDAZOLINE AND SEROTONIN RECEPTORS AND THE USE THEREOF |
| 07/02/2009 | WO2009082227A1 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent |
| 07/02/2009 | WO2009082203A1 Liquid nucleotides/nucleosides-containing product |
| 07/02/2009 | WO2009082039A1 Ampa receptor antagonists for epilepsy, mental disorders or deficits in sensory organ |
| 07/02/2009 | WO2009082038A2 Ampa receptor antagonists and zonisamide for epilepsy |
| 07/02/2009 | WO2009081991A1 Therapeutic agent for cerebral ischemic injury |
| 07/02/2009 | WO2009081892A1 Novel catechol derivative, pharmaceutical composition containing the same, and use of those |
| 07/02/2009 | WO2009081891A1 Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition |
| 07/02/2009 | WO2009081833A1 Dried microorganism cell or microorganism extract containing stabilized (ss)-s-adenosyl-l-methionine, and method for production of the dried microorganism cell or microorganism extract |
| 07/02/2009 | WO2009081789A1 Sulfonyl substituted 6-membered ring derivative |
| 07/02/2009 | WO2009081564A1 DAPKs INHIBITOR |
| 07/02/2009 | WO2009081395A1 A method of treating neurodegenerative diseases |
| 07/02/2009 | WO2009081259A1 Phenoxy-pyridyl derivatives |
| 07/02/2009 | WO2009081246A2 Bicyclic diamines as nicotinic receptor agonists |
| 07/02/2009 | WO2009081222A1 Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands |
| 07/02/2009 | WO2009081208A1 Processes to pregabalin |
| 07/02/2009 | WO2009080682A1 Pyrrolo[2,3-d]pyrimidine derivatives as cgrp receptor antagonists |
| 07/02/2009 | WO2009080651A1 Dosing regimen associated with long acting injectable paliperidone esters |
| 07/02/2009 | WO2009080637A1 Compounds which potentiate the ampa receptor and uses thereof in medicine |
| 07/02/2009 | WO2009080533A1 Heteroaryl derivatives as orexin receptor antagonists |
| 07/02/2009 | WO2009080470A1 Alpha-aminoamide derivatives useful in the treatment of psychiatric disorders |
| 07/02/2009 | WO2009080365A1 Pregabalin salts |
| 07/02/2009 | WO2009080301A1 Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke |
| 07/02/2009 | WO2009080268A1 Pharmaceutical for the treatment of phantom phenomena |
| 07/02/2009 | WO2009080223A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2009 | WO2009079911A1 Pegylated erythropoietin conjugate and preparation method and uses thereof |
| 07/02/2009 | WO2009079902A1 The preparation and use of a curcumin-zinc compound and its solid dispersion |
| 07/02/2009 | WO2009079790A1 Polypeptide-nucleic acid conjugates and uses thereof |
| 07/02/2009 | WO2009079765A1 Compounds with activity at the 5-ht2c receptor |
| 07/02/2009 | WO2009079763A1 Fluorinated aryl amide compounds |
| 07/02/2009 | WO2009079739A1 The use of creatine pyroglutamicacid salt to facilitate increased neural health |
| 07/02/2009 | WO2009079683A1 Translocator protein ligands |
| 07/02/2009 | WO2009063364A3 Modulators of urotensin receptor and methods of use thereof |
| 07/02/2009 | WO2009046832A3 Short peptides used in medicine |
| 07/02/2009 | WO2009043797A3 Salts of a cgrp antagonist, method for producing the same and use thereof as drugs |
| 07/02/2009 | WO2009036149A9 Methods for treatment of degenerative disease associated with apoptosis |
| 07/02/2009 | WO2009033762A3 Use of endothelin-3 as a therapeutic agent |
| 07/02/2009 | WO2009033739A3 Use of a peptide as a therapeutic agent |
| 07/02/2009 | WO2009033678A3 Use of a tuftsin as a therapeutic agent |
| 07/02/2009 | WO2008156622A8 Humanized antibodies to amyloid beta |
| 07/02/2009 | WO2008068424A8 Substituted 2,5-dihydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 07/02/2009 | WO2008004013A8 Medicament for the enhancement of cognitive function and neuroprotection |
| 07/02/2009 | WO2007109045A8 Heterocyclic organic compounds for the treatment of in particular melanoma |
| 07/02/2009 | US20090172827 Kcnn3 as diagnostic and therapeutic target for neurodegenerative diseases |
| 07/02/2009 | US20090170957 Scyllo-inositol derivatives and their use in the treatment of diseases characterized by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence |
| 07/02/2009 | US20090170948 Crystal forms of O-desmethylvenlafaxine fumarate |
| 07/02/2009 | US20090170941 Pharmaceutical Compounds |
| 07/02/2009 | US20090170937 Amino Acid Derivatives |
| 07/02/2009 | US20090170916 4,5-substituted pyrazole-3-carboxylic acids/esters/salts; D-amino acid oxidase (DAAO) inhibitors; increase D-Serine level; reduce level of toxic products of D-Serine oxidation; activate N-methyl-D-aspartate NMDA-glutamate receptors; neuropathic agent, schizophrenia, Alzheimer's, anaxia |
| 07/02/2009 | US20090170911 Novel azole compound |
| 07/02/2009 | US20090170901 Benzoyl Urea Derivatives |
| 07/02/2009 | US20090170899 Stimulators of 5-HT4 receptors and uses thereof |
| 07/02/2009 | US20090170897 Method of Treating Neuropathic Pain |
| 07/02/2009 | US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application |
| 07/02/2009 | US20090170888 Antipruritic Agent for Pruritus Caused by Multiple Sclerosis |
| 07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170878 Macrocyclic compounds useful as bace inhibitors |
| 07/02/2009 | US20090170877 5,6-Trimethylenepyrimidin-4-one compounds |
| 07/02/2009 | US20090170868 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 07/02/2009 | US20090170867 Trpv1 antagonists including sulfonamide substituent and uses thereof |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170851 Chroman Compounds |
| 07/02/2009 | US20090170841 Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
| 07/02/2009 | US20090170838 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170835 Isoindoline derivatives |
| 07/02/2009 | US20090170833 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them |
| 07/02/2009 | US20090170831 Substituted lactams as inhibitors of abeta protein production |
| 07/02/2009 | US20090170830 Tricyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 07/02/2009 | US20090170814 Neurodegenerative disorders; antiinflammatory agents; antiischemic agents; neuropathic pain; antiepileptic agents; Parkinson's disease; Alzheimer's disease; antidiabetic agents; 3-(6-Hydroxy-2-methyl-3,4,7,8,9,10-hexahydro-7,10-methano-2H -benzo[h]chromen-2-yl)-propionic acid methyl ester |
| 07/02/2009 | US20090170813 Hypophosphorous Acid Derivatives and their Therapeutical Applications |
| 07/02/2009 | US20090170798 Highly safe intranasally administrable gene vaccines for treating alzheimer's disease |
| 07/02/2009 | US20090170789 Antioxidants for preventing and treating diseases caused by oxidative stress |
| 07/02/2009 | US20090170783 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 07/02/2009 | US20090170095 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM |
| 07/02/2009 | US20090169631 Micronized opioid compositions, formulations and dosage forms and methods of making same |
| 07/02/2009 | US20090169619 Carbamazepine extended release dosage form |
| 07/02/2009 | US20090169616 Formulation and method for the release of paroxetine in the large intestine |
| 07/02/2009 | US20090169614 Methods of suppressing microglial activation and systemic inflammatory responses |
| 07/02/2009 | US20090169606 Low Flexural Strength Transdermal Tobacco Alkaloid Patch |
| 07/02/2009 | US20090169596 Device for spinal cord nerve regeneration |
| 07/02/2009 | US20090169584 Treatment of sleep disturbances |
| 07/02/2009 | US20090169555 Administering the kinase to regulate mitogenesis, apoptosis, neuronal development, chemotaxis, angiogenesis or an inflammatory response inclding developmental retardation, excessive apoptosis, cancer, restenosis and diabetic neuropathy; screening for drugs that stimulate or inhibit lipid phosphorylation |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169542 Modulators of neuronal regeneration |
| 07/02/2009 | US20090169535 Treatment of epilepsy by expressing st3gal-iii |
| 07/02/2009 | US20090169533 Compositions and methods for treating neurodegenerative diseases |
| 07/02/2009 | US20090169508 Opioid and opioid-like compounds and uses thereof |
| 07/02/2009 | US20090169506 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 07/02/2009 | DE102007063056A1 New anthraquinone derivatives are protein kinase inhibitors useful e.g. to treat autoimmune-, inflammatory-, metabolic-, organ-, cardiovascular-, neurological and neurodegenerative-, hormone dependent-disease, asthma, depression and stroke |
| 07/02/2009 | CA2710441A1 Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| 07/02/2009 | CA2710152A1 Processes to pregabalin |
| 07/02/2009 | CA2710016A1 Translocator protein ligands |
| 07/02/2009 | CA2709662A1 A method of treating neurodegenerative diseases |
| 07/02/2009 | CA2709635A1 Polypeptide-nucleic acid conjugates and uses thereof |